S.M. Pharmaceuticals Private Limited

S.M. Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24230KA2018PTC119625 Incorporated 19 December 2018 ROC Bangalore HQ Bangalore, Karnataka, India
Under Insolvency Private Limited Company pharma
Data last updated
Revenue · FY 2021
₹15.49 Cr
▼ 12% YoY
Net profit · FY 2021
₹12.39 Lakh
Net margin 0.8%
EBITDA · FY 2021
₹3.82 Cr
EBITDA margin 24.7%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5.5 Cr
Issued & subscribed
Open charges
₹21.02 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
5
Provident fund records

About S.M. Pharmaceuticals Private Limited

Data last updated:

S.M. Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Gennex Health Care Private Limited. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 December 2018.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2018PTC119625. Its GSTIN is 29ABBCS2977H1ZX (Karnataka).

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.5 Cr. It is led by directors including Yashwanth Kanchu Raju and Kanchu Doraswamy Raju.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.

As per the financials filed for FY 2021, the company reported a revenue of ₹15.49 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹12.39 Lakh (net margin 0.8%) and EBITDA of ₹3.82 Cr (EBITDA margin 24.7%).

The company has about 5 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: SM Pharmaceuticals. As per MCA filings, the company has open charges of ₹21.02 Cr on record. Court records list 19 cases involving the company, including 5 filed by the company and 14 filed against it; 3 cases are pending.

The last known website on record is smpharmaceuticals.in.

Company details

CIN U24230KA2018PTC119625
Registration Number 119625
Incorporation Date 19 December 2018
ROC Bangalore
Listing Status Unlisted
Company Status Under CIRP
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Gennex Health Care Private Limited

Contact details

S.M. Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is smpharmaceuticals.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    44/8 Ground Floor, 15th Cross Malleshwaram, Bangalore, Karnataka, India – 560003
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of S.M. Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
S.M. Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

S.M. Pharmaceuticals operates one associated brand: SM Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer of generic finished formulationssmpharmaceuticals.in

Financials of S.M. Pharmaceuticals Private Limited

FY 2024 filings available

S.M. Pharmaceuticals Private Limited reported revenue of ₹15.49 Cr (down 12% YoY) for FY 2021.

Revenue · FY 2021
₹15.49 Cr ▼ 12%
Net profit · FY 2021
₹12.39 Lakh margin 0.8%
EBITDA · FY 2021
₹3.82 Cr margin 24.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 12%
EBITDA CAGR growth
1 year
▼ 7%

Revenue fell 12% in the latest year. EBITDA fell 7% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹15.49 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.82 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹12.39 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin24.7%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of S.M. Pharmaceuticals Private Limited, buy the company report.

Board of directors of S.M. Pharmaceuticals Private Limited

S.M. Pharmaceuticals has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Yashwanth Kanchu RajuDirector20 Dec 20232 Years 10 MonthsAs last reported
Kanchu Doraswamy RajuDirector20 Dec 20232 Years 10 MonthsAs last reported
Mallikarjuna Setty NethiIrp/Rp/Liquidator07 Jul 20251 Years 3 MonthsAs last reported
VedavathiDirector29 May 20251 Years 5 MonthsAs last reported
Suchithra RajaDirector29 May 20251 Years 5 MonthsAs last reported

Auditor

S.M. Pharmaceuticals Private Limited is audited by V SEKHAR & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
V SEKHAR & COFY 2021011487S

Shareholding

The shareholding of S.M. Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of S.M. Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹21.02 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹21.02 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Mar 2019100255128State Bank of India₹21.02 CrOpen

To see the full charge records of S.M. Pharmaceuticals Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for S.M. Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

S.M. Pharmaceuticals Private Limited has a workforce of 5 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.

Employee count
5
Active EPFO establishments
1
Employee growth
-28.57%

GST

S.M. Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29ABBCS2977H1ZXKarnatakaActive20 Feb 2019

To see the full GST registrations and return filing status of S.M. Pharmaceuticals Private Limited, buy the company report.

Recent activity

S.M. Pharmaceuticals Private Limited has 12 board changes on record since 2021: 5 appointments and 7 cessations. The latest: Mallikarjuna Setty Nethi was appointed as Irp/Rp/Liquidator on 07 Jul 2025.

Appointed
Mallikarjuna Setty Nethi was appointed as Irp/Rp/Liquidator.
Appointed
Suchithra Raja was appointed as Director.
Appointed
Vedavathi was appointed as Director.
AGM
S.M. Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
S.M. Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Ceased
Kootgal Varadaiah Rashmi ceased to be Additional Director.
Ceased
Subramanyam Sharma ceased to be Additional Director.
Appointed
Kanchu Doraswamy Raju was appointed as Director.
Appointed
Yashwanth Kanchu Raju was appointed as Director.
Ceased
Kanchu Doraswamy Raju ceased to be Director.
Ceased
Yashwanth Kanchu Raju ceased to be Director.
Charges
A charge with State Bank Of India of Rs. 21.02 Cr registered on 29 Mar 2019 with Charge ID 100255128 was modified on 17 Jan 2022.

5 earlier events are in the company report.

Frequently asked questions

S.M. Pharmaceuticals is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.

S.M. Pharmaceuticals is a company under insolvency, formerly operating as a private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 December 2018 and is registered under CIN U24230KA2018PTC119625. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

S.M. Pharmaceuticals has 5 current directors:

The latest financial statements of S.M. Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.

The CIN (Corporate Identification Number) of S.M. Pharmaceuticals is U24230KA2018PTC119625. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

S.M. Pharmaceuticals has open charges of ₹21.02 Cr and no satisfied charges on record as per latest MCA filings.

S.M. Pharmaceuticals has 19 court cases on record: 5 filed by the company and 14 filed against it. 3 are pending. Most are in the district courts.

S.M. Pharmaceuticals was incorporated on 19 December 2018. It is registered with the Registrar of Companies, Bangalore.

Mallikarjuna Setty Nethi was appointed as Irp/Rp/Liquidator on 07 Jul 2025. Suchithra Raja was appointed as Director on 29 May 2025. Vedavathi was appointed as Director on 29 May 2025. S.M. Pharmaceuticals has 12 board changes on record in total.

S.M. Pharmaceuticals can be reached through the website smpharmaceuticals.in. Its registered office is in Bangalore, Karnataka, India.